Clinical Trial Update: The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating tranexamic acid for the treatment of symptomatic subdural hematoma. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Unity Health Toronto | Conditions: Subdural Hematoma | Phase 3 | Status: NOT_YET_RECRUITING